(Q44413135)

2 December 2017

title

Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs (English)

1 reference

2 December 2017

1 reference

Bruce M Cohen

1

1 reference

2 December 2017

Sara Cherkerzian

2

1 reference

2 December 2017

Jianyi Ma

3

1 reference

2 December 2017

Nancy Ye

4

1 reference

2 December 2017

Carrie Wager

5

1 reference

2 December 2017

Nicholas Lange

6

1 reference

2 December 2017

language of work or name

1 reference

23 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

167

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

403-410

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-003-1423-0

2 December 2017

exact match

0 references

cites work

New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Symptoms, signs, and diagnosis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Recent advances in the neuropathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

The thalamus as a site of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Alterations of thalamic activity in schizophrenia and in response to antipsychotic drugs: studies in the legacy of Seymour S. Kety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Neuroleptic, antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine, and their metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Activation of midline thalamic nuclei by antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: a replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Organization of the afferent connections of the mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal topography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

The interface between dopamine neurons and the amygdala: implications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Response of the ventral pallidal/mediodorsal thalamic system to antipsychotic drug administration: involvement of the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Magnetic resonance imaging of brain in people at high risk of developing schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Serotonergic projections from the nucleus raphe dorsalis to the amygdala in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

MRI anatomy of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Distribution of effects of haloperidol on energy metabolism in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Differential induction of Fos-like-immunoreactivity in the extended amygdala after haloperidol and clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

The involvement of nucleus accumbens dopamine in appetitive and aversive motivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

An anatomy of schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Thalamic midline cell populations projecting to the nucleus accumbens, amygdala, and hippocampus in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Automated identification of Fos expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

fMRI during affect discrimination in bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-003-1423-0

Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens

21 January 2018

1 reference

12 December 2020

Monoamines and nitric oxide are employed by afferents engaged in midline thalamic regulation.

1 reference

12 December 2020

GABA receptors inhibited by benzodiazepines mediate fast inhibitory transmission in the central amygdala

1 reference

12 December 2020

Temporolimbic volume reductions in schizophrenia

1 reference

12 December 2020

A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia

1 reference

12 December 2020

Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity

1 reference

12 December 2020

Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain

1 reference

12 December 2020

New atypical antipsychotic medications

1 reference

12 December 2020

Induction of Fos-like-immunoreactivity in the central extended amygdala by antidepressant drugs

1 reference

12 December 2020

10.1007/S00213-003-1423-0

Identifiers

DOI

1 reference

2 December 2017

1 reference